ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

December Business & Regulatory Report included in this issue.

December 12, 2003

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

It’s Official; Most of NCI NTP contingent Will Move To N.C.

February 22, 1980

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001